The annual spring testing program for pituitary pars intermedia dysfunction (PPID) opens April 1 and concludes June 3, with final submissions due to Cornell Animal Health Diagnostic Laboratory by June 6. Boehringer Ingelheim, in conjunction with Cornell University, has offered tests in the spring and fall since 2013. Through the program, more than 50,000 horses have been tested.
“PPID is more prevalent than people may think,” said Steve Grubbs, DVM, PhD, DACVIM, Technical Services Manager at Boehringer. “By providing veterinarians with tests and other resources, the hope is that the clinical signs will be recognized earlier, the horse will be tested, receive a diagnosis, and begin appropriate treatment.”
The testing information can be accessed by veterinarians at IDPPID.com. Other resources on the site include:
- General information about PPID
- Clinical signs of PPID
- Updates on the diagnosis and management of PPID
- Why and how to test for PPID
- PPID research
- Forage testing resources
A fall testing program will be conducted Aug. 19 through Oct. 14, with final submissions due to Cornell Animal Health Diagnostic Laboratory by Oct. 17.
To learn more and to access these valuable resources, visit IDPPID.com.
About Boehringer Ingelheim
Boehringer Ingelheim provides innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to make a difference for people, animals, and society. Learn more at www.bi-animalhealth.com.
©2025 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-EQU-0095-2025
Stay in the know! Sign up for EquiManagement’s FREE weekly newsletters to get the latest equine research, disease alerts, and vet practice updates delivered straight to your inbox.
